SDI Net Margin
Delisted·Jul 7, 2026
The Net Profit Margin of SDI (SDI.AX) as of Sep 13, 2026 is 11.02 %. In the previous year, Net Profit Margin was 9.37 % — a change of 17.56% (higher).
Get this data via API
Financial Data API
Net Margin
11.02 %
YoY
17.56%
Last updated:
Net Profit Margin of SDI is 2026 11.02 % . Net Profit Margin of SDI was 2025 9.37 % . It decreases by 17.56% higher compared to the previous year.
SDI's net margin stands at 11.0%, broadly stable from 11.0% several years earlier.
The SDI Net Margin history
3 Years
10 Years
25 Years
Max
Net Margin
Date
Net Margin
Jan 1, 2018
7.60 AUD
Jan 1, 2019
9.21 AUD
Jan 1, 2020
6.29 AUD
Jan 1, 2021
10.95 AUD
Jan 1, 2022
7.65 AUD
Jan 1, 2023
6.54 AUD
Jan 1, 2024
9.37 AUD
Jan 1, 2025
11.02 AUD
| YEAR | Net Margin | YoY |
|---|---|---|
| 11.02 % | +17.56% | |
| 9.37 % | +43.24% | |
| 6.54 % | -14.51% | |
| 7.65 % | -30.12% | |
| 10.95 % | +74.13% | |
| 6.29 % | -31.70% | |
| 9.21 % | +21.23% | |
| 7.60 % | +0.89% | |
| 7.53 % | -26.29% | |
| 10.21 % | +13.10% | |
| 9.03 % | -8.81% | |
| 9.90 % | +11,853.96% | |
| 0.08 % | +137.19% | |
| 0.03 % | +58.34% | |
| 0.02 % | -66.25% | |
| 0.07 % | +18.19% | |
| 0.06 % | +139.99% | |
| 0.02 % | -72.41% | |
| 0.08 % | -26.35% | |
| 0.11 % | — |
Access this data via the Eulerpool API
SDI Stock analysis
What does SDI do? SDI Ltd is a British company specializing in the development and manufacture of scientific and medical devices. The company was founded by John Poulter in 1952 and is headquartered in Basingstoke, Hampshire.
The history of SDI Ltd began with the development of scientific measuring devices, particularly instruments for measuring optical signals. Over the years, the company has specialized in the development of devices for medical diagnostics and therapy.
SDI Ltd now operates in various areas. One of its main business fields is microbiology and infection prevention. The company offers a wide range of products including test systems for infectious diseases such as HIV, Hepatitis B and C, tuberculosis, and malaria.
Another business field of SDI Ltd is the development of devices for the diagnosis of cancer and other diseases. The company offers both instruments for tissue sampling as well as automated diagnostic systems.
SDI Ltd is also active in medical technology and offers a wide range of products, from simple instruments like thermal thermometers to complex surgical instruments and implants.
In addition to medical diagnostics and therapy, SDI Ltd is also active in the field of analytical technology. The company offers instruments for chemical analysis, environmental monitoring, and food sampling.
The business model of SDI Ltd is based on the development and manufacture of high-quality and reliable devices for scientific, medical, and industrial use. The company relies on close collaboration with customers and partners to provide innovative solutions for the challenges of modern science and medicine.
An important part of SDI Ltd's business model is research and development. The company invests a significant portion of its revenue in the development of new products and technologies to always offer its customers the latest and best solutions.
Overall, SDI Ltd has established itself as a leading company in the field of scientific and medical devices. The company has a long history of successful product developments and is known for its high quality, reliability, and innovation. With its wide range of products and its commitment to research and development, SDI Ltd is well-equipped to continue playing an important role in science and medicine in the future. SDI is one of the most popular companies on Eulerpool.
Frequently Asked Questions about SDI stock
Net Profit Margin of SDI is 11.02 % in 2026.
Net Profit Margin of SDI changed from 9.37 % to 11.02 %, representing a 17.56% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Net Profit Margin SDI since 2006 – with annual values, charts, and detailed analysis.
Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's SDI with sector peers and the industry average to assess whether it is attractive.
To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.
Access this data via the Eulerpool API
Margins — SDI
All Key Metrics — SDI
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth